FOLATE RECEPTOR OF HUMAN MAMMARY ADENOCARCINOMA

Citation
J. Holm et al., FOLATE RECEPTOR OF HUMAN MAMMARY ADENOCARCINOMA, APMIS. Acta pathologica, microbiologica et immunologica Scandinavica, 102(6), 1994, pp. 413-419
Citations number
29
Categorie Soggetti
Pathology,Microbiology,Immunology
ISSN journal
09034641
Volume
102
Issue
6
Year of publication
1994
Pages
413 - 419
Database
ISI
SICI code
0903-4641(1994)102:6<413:FROHMA>2.0.ZU;2-0
Abstract
Binding of H-3-folate to human mammary tumor homogenate was of a high- affinity type (K=10(10) M(-1)) and displayed apparent positive coopera tivity. Radioligand dissociation was slow at pH 7.4, but rapid at pH 3 .5. As compared to methotrexate, 5-formyltetrahydrofolate acted as a s trong inhibitor of radioligand binding. Gel chromatography of radiolig and-labeled homogenate of tumor tissue revealed three peaks: a small g reater than or equal to 110 kDa peak and two major peaks of folate-bin ding activity (M(r) similar to 25 kDa and M(r) similar to 100 kDa). Ma mmary tumor tissue showed immunostaining with rabbit antibodies agains t human milk folate binder. A parallel elevation in the concentrations of folate-binding protein and triglyceride in tumor tissue as compare d to normal tissue adjacent to the tumor was compatible with the local ization of folate-binding protein in the triglyceride-rich fraction of mammary gland homogenate.